87 Cancer treatment often struggles with a familiar problem. Therapies that damage tumours can also harm healthy cells, leading to serious side effects and limiting how aggressively doctors can treat the disease. New research suggests a way to tip that balance, using the chemistry already inside cancer cells to destroy tumours more precisely. The findings were published in Advanced Functional Materials. Scientists have developed a microscopic iron based structure that triggers a powerful chemical reaction only inside cancer tissue. The approach exploits a known weakness of tumours, which contain higher levels of hydrogen peroxide and acidity than normal cells. By turning those conditions against the cancer, the treatment generates toxic oxygen molecules exactly where they are needed. The study focuses on a specially engineered metal organic framework made with ferrous iron. These frameworks are tiny, porous structures that can carry out chemical reactions inside the body. In this case, the researchers designed a needle shaped particle that dramatically increases its active surface area once it enters a tumour. Inside cancer cells, the particle sparks two destructive reactions at the same time. One produces hydroxyl radicals, among the most aggressive molecules known in biology. The other generates singlet oxygen, a highly reactive form of oxygen already used in some light based cancer therapies. Crucially, this new method does not require lasers or external energy to work. Laboratory tests showed that the nanoagent produced large amounts of these toxic oxygen species in cancer cells while leaving healthy cells largely unaffected. Non malignant cells exposed to the same particles showed minimal chemical stress, suggesting a level of selectivity rarely seen in treatments that rely on oxidative damage. The team then tested the therapy in mice with aggressive breast cancer tumours. After being injected into the bloodstream, the particles accumulated in tumour tissue and triggered intense chemical activity inside the cancer. Tumours rapidly shrank and, in most animals, disappeared completely. Even more striking was what happened next. Over several weeks of follow up, most treated mice showed no signs of the cancer returning. Throughout the experiment, the animals maintained normal body weight and showed no evidence of damage to major organs, blood chemistry, or immune function. The results suggest that combining two oxygen based attack mechanisms into a single nano-therapy may be far more effective than existing approaches that rely on just one. Because the reaction is driven by the tumour environment itself, the treatment remains inactive elsewhere in the body, reducing collateral damage. While the work is still at a preclinical stage, it highlights a growing shift in cancer research. Rather than overwhelming the body with toxic drugs, scientists are increasingly designing treatments that respond intelligently to the biology of disease. If future studies confirm its safety and effectiveness, this strategy could offer a new option for hard to treat cancers that resist conventional therapy.